Harrow Health 8625 Stock Price Prediction
HROWL Stock | USD 25.39 0.04 0.16% |
Oversold Vs Overbought
52
Oversold | Overbought |
Using Harrow Health hype-based prediction, you can estimate the value of Harrow Health 8625 from the perspective of Harrow Health response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Harrow Health to buy its stock at a price that has no basis in reality. In that case, they are not buying Harrow because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Harrow Health after-hype prediction price | USD 25.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Harrow |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Harrow Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Harrow Health After-Hype Price Prediction Density Analysis
As far as predicting the price of Harrow Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Harrow Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Harrow Health, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Harrow Health Estimiated After-Hype Price Volatility
In the context of predicting Harrow Health's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Harrow Health's historical news coverage. Harrow Health's after-hype downside and upside margins for the prediction period are 25.12 and 25.66, respectively. We have considered Harrow Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Harrow Health is very steady at this time. Analysis and calculation of next after-hype price of Harrow Health 8625 is based on 3 months time horizon.
Harrow Health Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Harrow Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Harrow Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Harrow Health, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.03 | 0.27 | 0.00 | 0.00 | 2 Events / Month | 1 Events / Month | In a few days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
25.39 | 25.39 | 0.00 |
|
Harrow Health Hype Timeline
Harrow Health 8625 is currently traded for 25.39. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Harrow is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.03%. %. The volatility of related hype on Harrow Health is about 173.08%, with the expected price after the next announcement by competition of 25.39. The company last dividend was issued on the 31st of July 2024. Assuming the 90 days horizon the next anticipated press release will be in a few days. Check out Harrow Health Basic Forecasting Models to cross-verify your projections.Harrow Health Related Hype Analysis
Having access to credible news sources related to Harrow Health's direct competition is more important than ever and may enhance your ability to predict Harrow Health's future price movements. Getting to know how Harrow Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Harrow Health may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
BWSN | Babcock Wilcox Enterprises, | 0.1 | 1 per month | 0.67 | 0.05 | 1.49 | (1.41) | 4.68 | |
BWNB | Babcock Wilcox Enterprises | (0.01) | 1 per month | 0.89 | 0.04 | 2.06 | (1.89) | 6.48 | |
RILYT | B Riley Financial | 1.11 | 3 per month | 4.67 | 0.03 | 10.55 | (9.24) | 36.84 | |
RILYO | B Riley Financial | (0.42) | 1 per month | 0.42 | (0.18) | 1.20 | (0.86) | 2.95 | |
SPNT-PB | SiriusPoint | 0.00 | 0 per month | 0.00 | (0.26) | 0.52 | (0.36) | 1.27 |
Harrow Health Additional Predictive Modules
Most predictive techniques to examine Harrow price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Harrow using various technical indicators. When you analyze Harrow charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Harrow Health Predictive Indicators
The successful prediction of Harrow Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Harrow Health 8625, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Harrow Health based on analysis of Harrow Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Harrow Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Harrow Health's related companies. 2023 | 2024 (projected) | Dividend Yield | 6.32E-4 | 6.0E-4 | Price To Sales Ratio | 2.81 | 2.67 |
Story Coverage note for Harrow Health
The number of cover stories for Harrow Health depends on current market conditions and Harrow Health's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Harrow Health is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Harrow Health's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Harrow Health Short Properties
Harrow Health's future price predictability will typically decrease when Harrow Health's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Harrow Health 8625 often depends not only on the future outlook of the potential Harrow Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Harrow Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 32.6 M | |
Cash And Short Term Investments | 82.8 M |
Check out Harrow Health Basic Forecasting Models to cross-verify your projections. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Equity 0.4484 |
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.